Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment.

This study illustrated the deliverability of sulfomucin in the disease-relevant grafting model to design sulfomucin-producing epithelial units in severely injured distal colon. The current study is the basis for the better promotion of organoids transplantation therapy for refractory UC.